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Abstract—The therapeutic use of microbubbles for targeted
drug or gene delivery is a highly active area of research.
Phospholipid-encapsulated microbubbles typically have a
polydisperse size distribution over the 1-10 µm range and
can be functionalised for molecular targeting as well as
loaded with drug-carrying liposomes. Sonoporation through the
generation of shear stress on the cell membrane by microbubble
oscillations is one mechanism that results in pore formation
in the cell membrane and can improve drug delivery. A
microbubble oscillating at its resonant frequency would generate
maximum shear stress on a membrane. However, due to the
polydisperse nature of phospholipid microbubbles, a range of
resonant frequencies would exist in a single population. In this
study, the use of linear chirp excitations was compared with
equivalent duration and acoustic pressure tone excitations when
measuring the sonoporation efficiency of targeted-microbubbles
on human colorectal cancer cells. A 3-7 MHz chirp had the
greatest sonoporation efficiency of 26.9 ±5.6 %, compared with
16.4 ±1.1 % for the 1.32-3.08 MHz chirp. The equivalent 2.2
and 5 MHz tone excitations have efficiencies of 12.8 ±2.1 % and
15.6 ±1.1 %, respectively, which were all above the efficiency of
4.1 ±3.1 % from the control exposure.
Index Terms—Drug Delivery, Ultrasound Contrast Agents,
Targeted Microbubbles, Sonoporation, Linear Frequency Modu-
lation, Chirp.
I. INTRODUCTION
GAS bubbles that have been stabilised with a thin shellmaterial, typically phospholipids [1] or bio-compatible
polymers [2], are routinely used as ultrasound contrast agents
(UCA) as they are highly echogenic due to their compressible
nature [3], [4]. Enhancing the contrast in echocardiography or
improving signal-to-noise levels in Doppler imaging [5] are the
main clinical uses for UCA. There is significant interest in the
development of UCA, or microbubbles, as molecular imaging
and/or therapeutic agents [6]–[10] since microbubbles can be
conjugated with antibodies that target specific cell populations
in the vasculature.
The therapeutic potential of microbubbles is predominantly
as a delivery mechanism for drugs [11]–[14] or gene therapy
vectors [15]–[19] that can be released through microbubble
destruction by ultrasound pulses, or to enhance uptake of
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co-administered therapeutic agents. Additionally, mechanical
damage associated with microbubble activity also has thera-
peutic potential [20]. Given the ubiquitous use of diagnostic
ultrasound systems in the clinical environment, the infras-
tructure exists for targeted-microbubbles to be introduced for
minimally invasive therapies [21].
The release of a therapeutic payload from a molecular-
targeted microbubble would be achieved through its de-
struction from exposure to an ultrasound field. However, as
microbubbles interact strongly with an ultrasonic field, the
emitted/re-radiated pressure generated by microbubble oscilla-
tions could be used to enhance therapeutic efficiency though a
process called sonoporation. Sonoporation is a technique that
uses a combination of ultrasound and microbubbles to modify
the permeability of a cell membrane [22], [23].
Although the exact mechanisms for sonoporation are un-
clear, it is thought that the production of shear stress on the
cell surface by microbubble oscillations can result in an in-
creased membrane permeability [24]. Additional sonoporation
mechanisms such as the push and pulling behaviour resultant
from the expansion and compression phase of microbub-
ble oscillations near a membrane [12], [25], and acoustic
microstreaming [26] are also thought to generate transient
micropores through which a therapeutic agent can pass. Pores
can also be generated by the formation of micro-jets by a
microbubble undergoing non-spherical shape oscillations near
a cell [27], which can result in non-viable cells and may not be
useful for therapy in which the target cells must survive [28].
Phospholipid-encapsulated microbubbles typically have a
polydisperse size distribution over the 1-10 µm range and
can be functionalised for molecular targeting as well as
loaded with drug-carrying liposomes [29], [30]. Microfluidic
techniques for manufacturing monodisperse microbubble pop-
ulations are in use, but the concentrations generated from
these techniques are low when compared with available agents
currently in clinical use [31]. Nevertheless, there are efforts
to address this problem through generation in situ [32] or
multiplexed devices [33].
The ultrasound frequencies used for sonoporation studies
are typically below 2.5 MHz, with 1 MHz being a commonly
used value [34]. A lower frequency would enable the mi-
crobubbles to be exposed at a higher mechanical index [35],
[36], which might be needed in order to cause microbubble
IEEE TRANSACTIONS ON ULTRASONICS, FERROELECTRICS, AND FREQUENCY CONTROL, IN PRESS 2
destruction. A microbubble being excited by an ultrasound
field that is at its resonant frequency would generate maximum
shear stress on a cell membrane. However, phospholipid
microbubbles, commercial or otherwise, have a polydisperse
population and a range of resonant frequencies [37] would
exist in a single population. Thus the use of a single frequency
to excite the population may not be the most efficient method
for generation of shear stress on cell membranes.
The use of linear frequency modulated chirps in diag-
nostic ultrasound imaging is a method for improving the
signal-to-noise ratio and penetration depth of this imaging
technique [38]–[40]. They have also been implemented to
improve the contrast to tissue ratio when imaging with mi-
crobubbles [41], [42]. It has been proposed that due to the
polydisperse nature of microbubble populations, if the fre-
quency range of the chirp were to match those of the resonant
frequency of the population, a greater acoustic response could
be achieved [43].
The magnitude of shear stress incident on a cell from
an oscillating microbubble is related to their separation dis-
tance [24], which can also affect the binding of a targeting
ligand or antibody attached to the microbubble [44]. Primary
radiation force [45] is used to manipulate microbubble popu-
lations [46] to assist in the molecular targeting of microbub-
bles [44], [47], [48], by minimising the distance between the
cell and microbubble and thus maximising the incident shear
stress on the cell. A secondary radiation force can be generated
from the pressure gradients in the re-radiated ultrasonic field
caused by microbubble oscillations. Two microbubbles that are
excited either above or below their resonant frequency will
result in an attractive force. This force will be negative if the
microbubbles are oscillating out of phase [45]. The secondary
radiation force can result in the formation of large aggregates
of microbubbles [49]. It has been demonstrated theoretically
that the use of a chirp with a polydisperse population will
result in increased displacement of a microbubble population
over an equivalent tone and thus could be beneficial for
molecular targeting applications [50].
The aim of this study was to investigate whether the
chirp excitation of polydisperse microbubble populations
at low pressure amplitudes could be used to increase the
sonoporation efficiency of cells, when compared to equivalent
exposures at single frequencies.
II. MATERIALS AND METHODS
A. Microbubble Manufacture and Characterisation
The phospholipids were prepared by mixing 19 µL of
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and
6.5 µL of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-
N-[biotinyl(polyethylene glycol)-2000] (ammonium salt)
(DSPE-PEG2000 Biotin) (Avanti Polar Lipids, Alabaster,
AL, USA), which were dissolved in stock solutions of
chloroform with a concentration of 20 mg/ml. This resulted
in a mol% of 92.3 and 7.7 %, respectively. After the
chloroform had been evaporated using a vacuum desiccator,
the lipids were re-suspended in a buffered saline solution
of 99 % MilliQ water and 1 % (v/v) glycerine (Sigma-
Aldrich, St. Louis, MO, USA) containing (w/v) 4 % NaCl
in a single 1 mL vial using an ultrasound bath (U50,
Ultrawave Ltd, Cardiff, UK). The vial containing the lipid
solution was saturated with octafluoropropane (C3F8) gas
and sealed. Microbubbles were generated by agitating
this solution for 45 s in a CapMix mechanical shaker
(3M ESPE, St. Paul, MN, USA) at a total concentration of
1.3x1010 ±0.3x1010 microbubbles/ml. 97.5 µg of NeutrAvidin
(A2666, Invitrogen Life Technologies, Paisley, UK), a
biotin-binding protein, was added to 2 µg of anti-integrin
αvβ6-biotinylated polyclonal antibody (bs-5791R-Biotin,
Insight Biotechnology Ltd, Middlesex, UK) and incubated at
room temperature for 20 minutes, which was then added to
the microbubble solution and incubated at room temperature
for a further 15 minutes to generate targeted microbubbles,
using a one-pot approach. An immunofluorescent study
was performed to confirm that the microbubbles were
completely covered by fluorescent NeutrAvidin. A previous
study [51] compared the sonoporation efficiency of targeted
microbubbles and untargeted microbubbles, exposed to either
a 2.2 MHz tone or 1.32-3.08 MHz chirp pulses. Untargeted
microbubbles were manufactured by adding a biotinylated
isotype control (Rabbit DA1E mAb IgG XP, New England
Biolabs Ltd, Ipswich, MA, USA) to the microbubble solution.
In order to estimate the size distribution and concentra-
tion of the microbubbles, a 30 µl sample of 10x diluted
solution was placed on a microscope slide, which had a
chamber of fixed volume, and imaged using bright-field
microscopy (Eclipse Ti, Nikon Instruments Inc., Melville,
NY,USA) [52]. For small amplitude oscillations [53], the
resonant frequency, ωr, of an encapsulated microbubble that
incorporates both the affects of stiffness and viscous damping
of the shell [37] is given by
ω2r = ω
2
0 − 2β2
ω20 =
1
ρR20
[
3γ
(
P0 +
2σ
R0
+
Sp
R0
)
− 2σ
R0
− 3Sp
R0
]
β =
1
ρR20
[
2µ+
Sf
8piR0
]
(1)
where R0 is the equilibrium radius of the microbubble
(0.35-7.5 µm), ρ is the liquid density (998 kg/m3), γ is the
polytropic gas index (1.07), P0 is the hydrostatic pressure
(101 kPa), σ is the surface tension at the liquid gas interface
(0.0728 N/m) and µ is the liquid viscosity (0.001 Pa.s). The
values for shell stiffness, Sp, and viscosity, Sf , were 1 N/m
and 0.05x10−6 kg/s, respectively and were chosen to be
similar to a DefinityTM microbubble [54]–[56] which have a
similar shell composition and gas core to the microbubbles
used in this study.
B. Ultrasound System
Two unfocused ultrasound transducers with a centre fre-
quency of 2.2 or 5 MHz (V323 or V310, Element size
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Fig. 1. A schematic showing the apparatus used for this sonoporation study.
Cells were plated into a 24-well plate and microbubbles were added in the
presence of Propidium Iodide, which were then exposed to ultrasound. The
photograph inset shows the experimental apparatus within the bio-cabinet used
in this study.
6.35 mm, -6dB bandwidth 79.9 %, Olympus NDT Inc,
Waltham, MA, USA) were used to excite the microbubble
population with either a tone or chirp pulse. A chirp with a
-6dB bandwidth of 80 % was used for both transducers, which
gave frequency ranges of 1.32-3.08 or 3-7 MHz. A 0.1 mm
needle hydrophone (Precision Acoustics, Dorset, UK) was
used to calibrate the output RMS pressure of both transducers,
which was 110 kPa for all exposure parameters. For chirps,
a pre-distorted drive signal was used to compensate for the
transducer’s frequency response to ensure uniform pressure
amplitude across all frequencies.
A 10 µs duration burst with a pulse repetition frequency
(PRF) of 1 kHz was used to expose the cell population for
a total of 2 minutes. The transducers were mounted on a
micrometer XYZ stage (PT3/M, Thorlabs Inc, Newton, NJ,
USA) and positioned, in culture media, at 20 mm above the
cell monolayer. Calibration of these transducers was performed
at this distance to ensure that the ultrasound exposures were
equivalent for each exposure type. Fig. 1 shows a schematic
of the experimental setup used for this study. A high PRF
was used to ensure that the primary radiation force exerted
on the microbubble population was sufficient to push the
microbubbles into contact with the cell monolayer at the
bottom of the well, to aid binding. As all ultrasound exposures
were performed in a plastic well a reflection from the bottom
of the well was expected and had a reflection coefficient
of σr = 0.25. These reflections affected the radiation force
experienced by microbubbles distributed inside the media
due to constructive and destructive interference of the long
duration excitation waveform. However, the total net force was
downward thus bringing the targeted microbubbles into contact
with the cells. The targeted microbubbles that contributed
towards sonoporation were located close to the cell monolayer
and their proximity to the reflective boundary at the bottom
of the well was at least an order of magnitude smaller than
the shortest wavelength used in this study. Therefore it was
assumed that the microbubbles were exposed with the incident
pressure wave with minimal contribution from the reflected
pressure wave.
The ultrasound transducer was driven by a custom-built
single element drive system (Fig. 1), which was based on
the Ultrasound Array Research Platform architecture reported
previously [57]. The system is capable of driving transducer
loads with excitation signal amplitudes up to ±100 V using a
commercially available integrated circuit (MAX4811, Maxim
Integrated, San Jose CA, USA). This component operates in
a switched-mode, generating square-wave ‘pseudo-chirps’. A
novel pulse width-modulation technique has been developed
to provide output amplitude pressure control from the
switched-mode system [58]. This technique allows arbitrary
waveforms to be generated from the transducer, whilst
maintaining the simplicity of switched-mode circuits. For
this study, it was desirable to generate chirp sequences with
an applied amplitude taper that counteracted the frequency
characteristics of the transducer, thus equalising output
pressure across the bandwidth of the signal. The amplitude
function was derived from the inverse of the transducer’s
frequency response, and used in the design of each chirp
excitation signal. Wireless control of the drive system via
Bluetooth allowed for the entire experimental apparatus to be
located within a bio-cabinet in order to reduce unnecessary
cabling, minimise contamination risk and maintain sterility.
C. Cell Culture and Sonoporation Apparatus
Human mammalian HCT116 cells (American Type Cul-
ture Collection, Manassas, VA, USA) were used as a model
colorectal cancer cell line, for the uptake of a fluorophore
through sonoporation. The cells, with a passage number of
5, were seeded into each well of a 24-well plate with a
density of 1.55x105 cells per well and cultured for 24 hours in
RPMI 1640 media with 10 % Foetal Bovine Serum (Invitrogen
Life Technologies, Paisley, UK), at 37 ◦C in a humidified
atmosphere of 5 % C02 in air. The diameter of each well was
10 mm and the element of the ultrasound transducers was
6.25 mm. Cells were grown in monolayers up to a maximum
overall confluency of 80 %. Prior to ultrasound exposures, the
culture media in each well was replaced with 3 ml of media
that contained the membrane impermeable fluorescent marker,
Propidium Iodide (PI), (P3566, Invitrogen Life Technologies,
Paisley, UK) at a concentration of 0.5 µM. Targeted microbub-
bles were added into each well at a concentration of 8x105
microbubbles/ml, except the wells used for control exposures.
Sonoporation experiments were performed 24 h after seeding
and thus it was estimated that there was approximately a
microbubble to cell ratio of 3:1. The control measurements
were ultrasound exposures of cell populations in the absence of
microbubbles. Each exposure condition was repeated in three
separate wells. Cells were then washed twice with fresh media.
To measure cell viability, a CellTracker Green stain (C2925,
Invitrogen Life Technologies, Paisley, UK) was then added to
each well at a concentration of 2 µM and left to incubate
at 37◦C for 45 minutes. This fluorescent green stain was
used to indicate living viable cells since these reagents pass
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freely through the membranes. However, once inside a viable
cell, CellTracker Green is transformed into a cell-impermeant
reaction product. After incubation, a final wash with fresh
media was performed and then each well was imaged under
both bright-field and fluorescence.
Immunofluorescence was performed on HCT116 cells in
order to examine the presence of antigen (integrin αvβ6) used
for molecular-targeting of the microbubbles in this study [59].
Glass cover slips were seeded with 50000 cells and left to
culture for 48 hours and then fixed with 4 % paraformalde-
hyde in phosphate buffered saline (PBS) and followed by
two washes with PBS. To minimise non-specific binding,
blocking was performed using Antibody Diluent Reagent
Solution (Invitrogen Life Technologies, Paisley, UK) for 1
minute before application of the primary antibody or isotype
control (4096S, Rabbit DA1E mAb, New England Biolabs,
MA, USA), which were each incubated for 1 hour at room
temperature. The biotinylated antibody was applied at 1:50 di-
lution (concentration 1 mg/ml) and the isotype control at 1:100
(concentration 0.5 mg/ml). After washing, an AlexaFluor 488-
conjugated secondary antibody (AlexaFluor 488 donkey anti-
rabbit IgG, A-21206, Invitrogen Life Technologies, Paisley,
UK), was incubated with the cells for 30 minutes in the dark at
1:300 dilution (concentration 2 mg/ml). After further washing
with PBS the cover slips were mounted with Prolong Gold
containing DAPI (Invitrogen Life Technologies, Paisley, UK).
The fluorescent images were taken on a Zeiss Axio Imager
Z1 microscope (Carl Zeiss Microscopy LLC, NY, USA) with
AxioVision software, where the exposure times were kept
constant between each acquisition. A test performed with the
secondary antibody alone showed a similar staining to the
isotype control.
A flow assay was performed in order to determine specific
binding of microbubbles conjugated with the targeting anti-
body or an isotype control. HCT116 cells were seeded by
plating 30 µl of 5x105 cells/ml onto the upper surface of a
µ-Slide VI0.4 (ibidi, Thistle Scientific, Glasgow, UK) and left
to culture for 24 hours at 37 ◦C, in a humidified atmosphere
of 5 % C02 in air. The cells were washed with PBS, then a
solution containing 1x107 microbubbles/ml was flowed over
the cells at a rate of 0.2 ml/minute for a total of 4 minutes
using connecting tubing and a syringe driver (Aladdin AL-
2000, World Precision Instruments, Sarasota, FL, USA). This
flow corresponds to a shear rate of 40-50 s−1 and was chosen
to maximise microbubble attachment without shearing off cells
from the slide. In order to remove unbound microbubbles, PBS
was flowed over the cells at a rate of 3.40 ml/minute for a
total of 3 minutes. This flow corresponds to a shear rate of
600 s−1, which is equivalent to the wall shear rate found at
peripheral vessels in a glioma xenograft [60]. Five images of
microbubbles bound to cells were acquired using a camera
(C-7070, Olympus, Southend-on-Sea, UK) mounted onto an
inverted light microscope (CKX41, 40x objective, Olympus,
Southend-on-Sea, UK). The number of cells and the number of
attached microbubbles was manually counted in each picture,
with a mean number of cells per image of 122.
D. Analysis of Sonoporation Efficiency
Image sequences (bright-field and fluorescence) were ac-
quired at five unique locations within each well, with a field
of view of 205x153 µm. MatLab (Mathworks Inc, Natick,
MA, USA) was used for image processing of both the bright-
field and fluorescence images. A sequence of three images
were taken; the bright-field images were used to identify the
location and number of cells, and the average colour value was
calculated under both red and green fluorescence. Threshold
colour intensity values were identified from a well which had
neither ultrasound nor microbubbles added to it, and only when
both the respective average fluorescence values exceeded these
values was a cell considered to be stained. PI is generally used
to identify dead cells [61], [62], and this stain was used to
avoid including dead or damaged cells.
An average of between 200-500 cells were imaged over the
five unique locations in each well, which was then repeated
three times for each exposure condition. Sonoporation
efficiency was defined as the percentage of cells that had been
stained with both red and green fluorescence. Cell viability
was defined as the percentage of cells that were stained with
CellTracker green, compared with the total number of cells
imaged.
III. RESULTS
Fig. 2(a) shows the measured size distribution for the
microbubble population used in this study. The mean diameter
and standard deviation for these microbubbles, based on mea-
surements from five individual preparations, was 2.4 ±1.0 µm.
Fig. 2(b) shows the simulated range of resonant frequencies
that was encompassed by the different sizes of this microbub-
ble population. The two filled in areas under this curve show
the range of resonant frequencies excited by either a 1.32-
3.08 or 3-7 MHz chirp, which cover approximately 16.7 and
51.5 %, respectively, of this polydisperse population. However,
the areas covered by tone excitations at 2.2 or 5 MHz excite
approximately 1.5 and 1.3 % of the microbubble population
at their resonance frequency, which is significantly lower than
chirp excitation.
Fig. 3 shows the fluorescent staining of cells for the (a)
integrin targeted and (b) isotype control antibodies. The bright
green fluorescence staining in (a) shows the presence of the
target antigen (integrin αvβ6) on the HCT116 cells that was
used for microbubble targeting. A blue fluorescent stain was
used to identify the cell nucleus. The fluorescent staining
pattern shows the integrin is present in the membrane and
cytoplasm and confirms the presence of the target antigen on
these cells. This demonstrated that the antibody attached to the
microbubbles was successfully targeted to the cell line used for
this sonoporation study. In Fig. 3(b) faint green fluorescence
is seen with the isotype control (exposure matched) indicating
that a small degree of non-specific binding may occur with
this antibody. Fig. 3(c) and (d) show two example images
of microbubbles bound to cells for both the integrin and
isotype control antibodies respectively. Fig. 3(e) shows that a
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Fig. 2. (a) The population density of the microbubble population used in this
study, which was normalised to the total number of microbubbles. The inset
shows an example image of a microbubble population (b) The corresponding
resonant frequency distribution of this polydisperse microbubble population.
Hashed region (I) shows the population of microbubbles excited for a 1.32-
3.08 MHz chirp and region (II) is for a 3-7 MHz chirp.
statistically significantly greater number of microbubbles bind-
ing to the HCT116 cells using integrin-targeted microbubbles
compared to isotype-targeted microbubbles.
Fig. 4 shows the frequency spectrum of the four different ex-
posure types measured using the needle hydrophone. Fig. 4(a)
gives the frequency spectrum for the tone and chirp pulses
generated using the 2.2 MHz transducer, where (b) is the fre-
quency spectra generated with the 5 MHz transducer. The total
power spectral density integrated over the 1-10 MHz range
for each of these signals was approximately 5x104 dB/Hz2,
thus ensuring equivalent acoustic energy was delivered to the
microbubble populations, irrespective of the exposure type.
Fig. 5, which has been reproduced from [51], shows the
sonoporation efficiency for targeted and non-targeted mi-
crobubbles that have either been exposed to 2.25 MHz tone
or 1.32-3.08 MHz chirp excitations. In addition, cells that had
been exposed to a chirp excitation in the absence of microbub-
bles were used as a control. Although the overall sonoporation
efficiency was below 21 %, targeted microbubbles that were
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Fig. 3. Immunofluorescence images of HCT116 cells imaged under combined
DAPI and FITC fluorescent filters for the (a) integrin antibody or (b) isotype
control. Green fluorescence staining indicates the presence of the targeted
antigen, where blue staining indicates cell nuclei. Microbubbles targeted with
either (c) integrin αvβ6 or (d) isotype control antibody were flowed over
HCT116 cells. In these images the microbubbles appear as white dots and are
highlighted with arrows. (e) The number of attached microbubbles per cell
for the integrin and isotype antibodies. ∗∗ shows statistical difference using
a two-tailed Mann-Whitney U test where p < 0.01.
exposed to a chirp excitation showed the highest sonoporation
efficiency, with an efficiency of 20.5 ±5.6 %. In addition,
for both ultrasound exposure types, targeted microbubbles
gave a higher efficiency when compared with non-targeted
microbubbles.
Fig. 6 shows a mosaic of images taken under bright-field,
red and green fluorescence for a single 205x153 µm location
in each of the wells of diameter 10 mm, which were exposed to
110 kPa RMS pressure. The control exposure (Fig. 6a) was the
only one of this sequence that was exposed without the pres-
ence of targeted-microbubbles. Fig. 6(b) and (c) were exposed
using the lower frequency transducer with a 2.2 MHz tone and
1.32-3.08 MHz chirp, where (d) and (e) were the 5 MHz tone
and 3-7 MHz exposures using the higher frequency transducer.
The green stain indicates that these cell populations were
viable. In this figure, cells stained both red and green were
present only where microbubbles were introduced, indicative
of sonoporation occurring in these cells. However, it is worth
noting that even in the absence of microbubbles some viable
cells had PI uptake. The cell viability for the control, 2.2 MHz
tone and chirp, 5 MHz tone and chirp exposures was measured
to be 98 ±2.1 %, 98 ±0.9 %, 98 ±0.8 %, 96 ±3.0 % and
IEEE TRANSACTIONS ON ULTRASONICS, FERROELECTRICS, AND FREQUENCY CONTROL, IN PRESS 6
(a)
M
ag
ni
tu
de
 (d
B
)
Frequency (MHz)
(b)
M
ag
ni
tu
de
 (d
B
)
Frequency (MHz)
Fig. 4. (a) The measured frequency spectrum for the tone and chirp pulses
centred at 2.2 MHz. (b) The corresponding frequency spectrum for the tone
and chirp pulses centred at 5 MHz.
96 ±1.6 %, respectively.
Fig. 7 shows the sonoporation efficiency in HCT116 cells
for targeted microbubbles that have been exposed to (b)
2.2 MHz tone, (c) 1.32-3.08 MHz chirp, (d) 5 MHz tone or (e)
3-7 MHz chirp excitations. Fig. 7(a) shows the sonoporation
efficiency for the control exposure, comprised of cells exposed
to a 3-7 MHz excitation in the absence of microbubbles. The
high frequency chirp (Fig. 7e) showed the greatest sonopora-
tion efficiency of 26.9 ±5.6 %, compared with 16.4 ±1.1 % for
the lower frequency chirp. Similarly the 2.2 and 5 MHz tone
excitations has efficiencies of 12.8 ±2.1 % and 15.6 ±1.1 %,
respectively.
A sonoporation efficiency of 4.1 ±3.1 % was achieved with
the control exposure. A one-way analysis of variance test
demonstrates that the means of the different exposure groups
in Fig. 7 were significantly different with p < 0.0001. Further
analysis using the Bonferroni’s post-hoc test to compare each
group with every other indicates that only the efficiency
measured for 2.2 MHz tone excitations was not significantly
different to the control measurements. Analysis also showed
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Fig. 5. The average sonoporation efficiency for targeted or un-targeted
microbubbles exposed to (a) control, (b & d) 2.2 MHz tone, (c & e) 1.32-
3.08 MHz chirp excitations. Error bars show the standard deviation of three
repeat measurements. ∗ shows statistical difference from (a) the control
measurement, with p < 0.05, using the Bonferroni’s post-hoc test.
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Fig. 6. A mosaic of (I) bright-field, (II) red and (III) green fluorescence
images for the (a) control, (b) 2.2 MHz tone and (c) chirp, (d) 5 MHz tone
and (e) chirp exposures.
that the measured efficiency for the 3-7 MHz chirp exposure
was significantly greater than the other exposure conditions.
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Fig. 7. The average sonoporation efficiency for targeted microbubbles
exposed to (a) control, (b) 2.2 MHz tone, (c) 1.32-3.08 MHz chirp, (d) 5 MHz
tone and (e) 3-7 MHz chirp excitations. Error bars show the standard deviation
of three repeat measurements. ###, ## or # show statistical difference from
(a) the control measurement, with p < 0.001, 0.01 or 0.05 respectively, using
the Bonferroni’s post-hoc test. ∗∗ or ∗ show statistical difference from (e) the
5 MHz chirp excitation, with p < 0.01 or 0.05.
IV. DISCUSSION
The sonoporation efficiencies achieved in HCT116 cells for
this study were between 12-27 % for all exposure conditions
with targeted microbubbles. However, the use of targeted mi-
crobubbles exposed to a chirp excitation resulted in the greatest
efficiency when compared with equivalent tone excitation. As
shown in Fig. 7, the highest efficiency was generated by a
chirp at 3-7 MHz followed by the 1.32-3.08 MHz chirp with
16.3 %. Cell viability was measured 45 minutes after exposure,
whereas later time points may have shown greater cell death
and thus affect the sonoporation efficiency is a limitation of
this study. The reported sonoporation efficiency of 4.1 ±3.1 %
for the control measurements shows a very low uptake of PI
into viable cells in the absence of microbubbles. It has been
widely reported that ultrasound exposures alone are sufficient
to result in uptake into the cell, but as greatly reduced levels
when compared with ultrasound and microbubbles [19].
The resonant frequencies predicted by Eq. (1) for the size
distribution of this specific microbubble population is shown in
Fig. 2, which highlights that the higher frequency chirp would
excite approximately 51.5 % of the population at resonance,
compared with 16.7 % for the lower frequency chirp. The ac-
curacy of this estimation could be improved by using measured
shell parameters for this specific population. Furthermore, in
this study a constant chirp rate was used, thus fixing the
exposure duration at a specific frequency. A further increase in
the sonoporation efficiency could possibly be achieved through
the use of a non-linear chirp rate. This chirp rate would be
defined by the measured resonant response of the polydisperse
microbubble population used and would ensure that a greater
population of microbubbles at a specific size would experience
excitation at resonance for longer in an effort to maximise the
shear stress generated on the cells. In addition, transducers
with a broader bandwidth, such as capacitive micromachined
ultrasonic transducers (CMUTs) [63] could be used to increase
the population of microbubbles excited at resonance without
the need to sacrifice output power. This would allow for higher
acoustic pressures to be tested, which is a limitation of this
study. The primary aim of this study was to compare tone
and chirp excitations for the sonoporation of cancer cells and
thus an exposure duration of 2 minutes was chosen, from
a large variation of exposure times [34], to ensure adequate
time for primary radiation force to bring the microbubbles
into contact with the cells and for sonoporation to occur.
However, this duration could be optimised by monitoring
the acoustic backscatter from microbubbles so that exposures
could last until the microbubble population has diminished,
thus maximising the time for sonoporation to occur. Further
optimisation could be achived through increasing the duration
and PRF of the ultrasound exposure, but this could result in
decreased cell viability [64].
Fig. 5 shows a the sonoporation efficiency of targeted and
un-targeted microbubbles exposed to both tone and chirp
pulses. In this example the targeted microbubbles exposed
to a chirp excitation preformed than equivalent exposure
without targeting. The magnitude of shear-stress experienced
by a cell is dependent on the separation distance between
the cell and microbubble [24]. Thus, bound microbubbles
may show increased sonoporation efficiency due to being in
close proximity to the cells for the duration of the ultrasound
exposure when compared with free microbubbles.
As the microbubbles were introduced into the media and
uniformly distributed, primary radiation force was used to
bring them into contact with the cell populations to facilitate
binding and sonoporation. However, secondary radiation force
effects resultant from microbubble oscillations have been
shown [65] to cause clusters of microbubbles around individ-
ual cells or have sufficient force to break molecular bonds [66].
This clustering effect due to secondary radiation force could
have impacted the overall sonoporation efficiency in this study
since the microbubble population is not evenly distributed
over all of the cells, and could be restricted to individual
locations on the cell. In a sonoporation study using targeted
microbubbles to deliver PI into endothelial cells, Kooiman
et al, [67] demonstrated that the location of attachment of
targeted microbubbles did not affect the sonoporation of the
cell, but also observed that sonoporation did not always occur
with a microbubble located on a cell. A possible cause for
this may have been due to driving microbubbles off-resonance
with a 1 MHz tone excitation, as a polydisperse microbubble
population was used [68]. This study demonstrated that a
single targeted microbubble on a cell can result in sonoporation
and thus the formation of microbubble aggregates on single
cells would be an inefficient technique for drug delivery.
However, this effect is increased through the experimental
arrangement used in this study and may not be a significant
problem in vivo.
An inverse filter based on the transducer’s transfer function
was used to pre-distort the electrical drive signal to ensure
that the RMS pressure was kept constant at 110 kPa for
each exposure parameter, and thus compensate for the
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transducer’s frequency response. In order to increase the
spectral energy, the maximum peak pressure achievable
with this system was limited when compared with the tone
excitations. However, this technology has been implemented
into an array system [58], which will be able to provide RMS
pressures at higher amplitudes. Furthermore, the integration
of pre-distorted chirp pulses into diagnostic ultrasound
systems could provide a valuable tool in the clinical use of
microbubbles for targeted drug delivery.
V. CONCLUSIONS
This study demonstrated that the use of chirp excitation
of molecular-targeted polydisperse microbubble populations
resulted in higher sonoporation efficiencies of cultured cell
monolayers when compared with tone bursts of equivalent
duration and RMS pressure. A 3-7 MHz pre-distorted chirp
showed the greatest sonoporation efficiency of 26.9 ±5.6 %,
which might be further, improved through the use of non-
linear chirp excitation.
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